Recently diagnosed sexually HIV-infected patients: seroconversion interval, partner notification period and a high yield of HIV diagnoses among partners

被引:0
|
作者
Worm, AM
Bird, SM
Holmstrom, P
Smith, E
Valle, SL
Colpin, H
Clumeck, N
Worm, AM
Smith, E
Fenton, K
French, R
Holmstrom, P
Haikala, O
Valle, SL
Roumeliotou, A
Papaevangelou, G
Moi, H
Due-Tonnesen, U
Bird, SM
Mir, N
Ramstedt, K
Raado, G
机构
[1] MRC, Biostat Unit, Cambridge CB2 2SR, England
[2] Hop St Pierre & Erasme, Div Infect Dis, Brussels, Belgium
[3] State Serum Inst, Dept Epidemiol, Copenhagen, Denmark
[4] Bispebjerg Hosp, Dept Dermatovenerol, DK-2400 Copenhagen, Denmark
[5] Mortimer Market Ctr, London, England
[6] Univ Helsinki, Cent Hosp, Helsinki, Finland
[7] Natl Publ Hlth Inst, Helsinki, Finland
[8] Athens Sch Publ Hlth, Athens, Greece
[9] Olafiaklinikken, Oslo, Norway
[10] Glasgow Royal Infirm, Dept Genitourinary Med, Glasgow G4 0SF, Lanark, Scotland
[11] Natl Publ Hlth Inst, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We collected data on the outcome of partner notification (PN) for 356 index patients (iPs) newly diagnosed with HIV, all sexually infected, in six European countries, 1995-96. The PN period (the period during which exposed partners should be notified about their risk of being HIV infected) could be defined on the basis of last negative HIV test in 170/356 (48%), from other key dates for 12, and for 14 more on the sole basis of known HIV exposure (total 196/356, 55%), However, of the 170 iPs with a last negative HIV test date, PN period was not defined in 52 (31%), even though 28/52 were recent seroconverters (negative HIV test within 24 months of HIV diagnosis). Discrepancies in PN period evaluation were common: of the 85 iPs for whom PN period was reportedly defined as '3 months before last HIV-negative date', the period actually used was equal to this in only 12. A user-friendly worksheet would simplify the task of eliciting and using key dates to define the PN period. Forms on PN outcome were received for 166/200 (83%) reported current partners, but only 124/508 (24%) ex-partners. Fifty-two of 290 (18%) notified partners already knew they were HIV-positive, and 38/130 (29%) notified partners for whom pre-PN status was negative or unknown were HIV-positive on post-PN testing. Results of HIV tests (if any) after PN were unknown for 37/133 (28%) current partners not already known to be HIV-positive, and for 71/105 (68%) ex-partners-a doubling of the information loss rate. Notification of 133 current and 105 ex-partners not previously identified as HIV-positive thus produced 28 (21%) and 10 (10%) new HIV diagnoses, respectively. The total yield of HIV diagnoses was 38/100 (38%) partners of recent seroconverters (22 already known plus 16 PN-diagnosed), compared with 52/190 (27%) partners of other iPs (30 already known plus 22 PN-diagnosed). We propose prioritization for PN of partners of recent seroconverters, augmented surveillance for HIV diagnoses and recurrence in PN networks of at-risk, non-notified partners, and new measures that preserve anonymity to alert potential and past sexual contacts of HIV-diagnosed individuals who are unable or unwilling to assist in PN.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 50 条
  • [1] Exposure to HIV Partner Counseling and Referral Services and Notification of Sexual Partners among Persons Recently Diagnosed with HIV
    MacKellar, Duncan A.
    Hou, Su-I
    Behel, Stephanie
    Boyett, Brian
    Miller, David
    Sey, Ekow
    Harawa, Nina
    Prachand, Nik
    Bingham, Trista
    Ciesielski, Carol
    SEXUALLY TRANSMITTED DISEASES, 2009, 36 (03) : 170 - 177
  • [2] PARTNER NOTIFICATION PRACTICES AMONG HIV-INFECTED MEN
    Edelman, E. J.
    Gordon, Kirsha S.
    Hogben, Matthew
    Crystal, Stephen
    Bryant, Kendall
    Justice, Amy C.
    Fiellin, David A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S134 - S135
  • [3] HIV-infected individuals as partners in prevention: A redefinition of the partner notification process
    Golub, Sarit A.
    Indyk, Debbie
    SOCIAL WORK IN HEALTH CARE, 2006, 42 (3-4) : 225 - 235
  • [4] Clinico-epidemiological characteristics of recently diagnosed HIV-infected patients
    de Munain, JL
    Santamaría, JM
    Cámara, MM
    Zubero, Z
    MEDICINA CLINICA, 2002, 119 (06): : 238 - 239
  • [5] HIV partner notification outcomes for HIV-infected patients by duration of infection, San Francisco, 2004 to 2006
    Ahrens, Katherine
    Kent, Charlotte K.
    Kohn, Robert P.
    Nieri, Giuliano
    Reynolds, Andrew
    Philip, Susan
    Klausner, Jeffrey D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (04) : 479 - 484
  • [6] Sexual Partner Notification of HIV Infection Among a National United States-Based Sample of HIV-Infected Men
    E. J. Edelman
    K. S. Gordon
    M. Hogben
    S. Crystal
    K. Bryant
    A. C. Justice
    D. A. Fiellin
    AIDS and Behavior, 2014, 18 : 1898 - 1903
  • [7] Sexual Partner Notification of HIV Infection Among a National United States-Based Sample of HIV-Infected Men
    Edelman, E. J.
    Gordon, K. S.
    Hogben, M.
    Crystal, S.
    Bryant, K.
    Justice, A. C.
    Fiellin, D. A.
    AIDS AND BEHAVIOR, 2014, 18 (10) : 1898 - 1903
  • [8] Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals
    van Sighem, Ard
    Gras, Luuk
    Reiss, Peter
    Brinkman, Kees
    de Wolf, Frank
    AIDS, 2010, 24 (10) : 1527 - 1535
  • [9] Association of lean mass with bone mineral density in young, recently diagnosed HIV-infected patients
    Gallego Galiana, J.
    Vivancos, M.
    Gioia, F.
    Sobrino, C.
    Perez-Elias, M.
    Moreno, A.
    Moreno, S.
    Vazquez, M.
    Casado, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [10] High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children
    Vignoles, Moira
    Barboni, Grociela
    Agosti, Maria Rosa
    Quarleri, Jorge
    Garcia, Mariel Karina
    Giraudi, Vera
    Ayala, Silvig Gonzalez
    Salomon, Horacio
    ANTIVIRAL THERAPY, 2007, 12 (07) : 1133 - 1137